Literature DB >> 18602466

Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier.

Maryam Hamzeh-Mivehroud1, Ali Mahmoudpour, Hasan Rezazadeh, Siavoush Dastmalchi.   

Abstract

Phage display technology could provide a rapid means for the discovery of novel peptides and proteins from genetically engineered variants which may act as specific vehicles for drug delivery particularly through the intestinal barrier. In this work, we utilized in vivo phage display in order to study the sequences which may be responsible for transmucosal transport. We hypothesized that the introduction of a library of peptide displaying phages into the intestine may lead to the identification of sequences that could induce transport. A biopanning protocol was performed by applying a 7-mer random amino acid phage library to mice by gavage and then assessing their absorption via phage recovery from the spleen and blood. Following the isolation of 77 different phages, the sequences of the displayed peptides were identified. Statistical treatment of the obtained sequences did not support the notion that the GI translocation depends on the presence of any particular peptide sequence fused on the pIII coat proteins of the M13 phages. There are, however, some residue types underrepresented which could be due to specific GI selection mechanisms and/or their effects on the amplification rate for phages bearing those residues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602466     DOI: 10.1016/j.ejpb.2008.06.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

Review 1.  Bacteriophages and medical oncology: targeted gene therapy of cancer.

Authors:  Babak Bakhshinejad; Marzieh Karimi; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-07-11       Impact factor: 3.064

2.  Peptides as drug delivery vehicles across biological barriers.

Authors:  Debadyuti Ghosh; Xiujuan Peng; Jasmim Leal; Rashmi Mohanty
Journal:  J Pharm Investig       Date:  2017-12-12

3.  Ecological basis for rational phage therapy.

Authors:  A V Letarov; A K Golomidova; K K Tarasyan
Journal:  Acta Naturae       Date:  2010-04       Impact factor: 1.845

Review 4.  Gut inflammation and immunity: what is the role of the human gut virome?

Authors:  Alfredo Focà; Maria Carla Liberto; Angela Quirino; Nadia Marascio; Emilia Zicca; Grazia Pavia
Journal:  Mediators Inflamm       Date:  2015-04-07       Impact factor: 4.711

5.  Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells.

Authors:  Timo A Lehti; Maria I Pajunen; Maria S Skog; Jukka Finne
Journal:  Nat Commun       Date:  2017-12-04       Impact factor: 14.919

6.  Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages.

Authors:  Jonas D Van Belleghem; Frédéric Clement; Maya Merabishvili; Rob Lavigne; Mario Vaneechoutte
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

7.  Viral dysbiosis in children with new-onset celiac disease.

Authors:  Mohammad El Mouzan; Asaad Assiri; Ahmed Al Sarkhy; Mona Alasmi; Anjum Saeed; Abdulrahman Al-Hussaini; Badr AlSaleem; Mohammad Al Mofarreh
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

Review 8.  In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties.

Authors:  Ana S André; Isa Moutinho; Joana N R Dias; Frederico Aires-da-Silva
Journal:  Front Microbiol       Date:  2022-09-26       Impact factor: 6.064

9.  Resident viruses and their interactions with the immune system.

Authors:  Breck A Duerkop; Lora V Hooper
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.